Tenascin-C is not a useful marker for disease activity in psoriasis

Acta Dermato-Venereologica

Volumn 78, Issue 5, 1998, Pages 331-334

  Latijnhouwers, Mieke A H E ^a   Bergers, Mieke ^a   Kuijpers, Astrid L A ^a   Van Der Vleuten, Carine J M ^a   Dijkman, Henri ^a   Van De Kerkhof, Peter C M ^a   Schalkwijk, Joost ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Acitretin; Corticosteroid; Cyclosporin A; Methotrexate; Retinoic acid

Indexed keywords

CLOBETASOL PROPIONATE; DUODERM; DUODERM EG; ETRETIN; GLYCOPROTEIN; HYDROCORTISONE BUTYRATE; LOCOID CRELO; TENASCIN; UNCLASSIFIED DRUG;

ARTICLE; CLINICAL ARTICLE; DISEASE ACTIVITY; DISEASE MARKER; DOWN REGULATION; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PSORIASIS; REMISSION; SKIN BIOPSY; TOPICAL DRUG ADMINISTRATION;

EID: 0031830986     PISSN: 00015555     EISSN: None     Source Type: Journal    
DOI: 10.1080/000155598442980     Document Type: Article

References (20)

1. Schalkwijk J, van Vlijmen I, Oosterling B, Perret C, Koopman R, van den Born J, et al. Tenascin expression in hyperproliferative skin diseases. Br J Dermatol 1991; 124: 13-20.
2. de Jong EMGJ, Schalkwijk J, van de Kerkhof PCM. Epidermal proliferation and differentiation, composition of the inflammatory infiltrate and the extracellular matrix in the margin of the spreading psoriatic lesion. Fur J Dermatol 1991; 1: 221-227.
3. Gerritsen MJP, Elbers ME, de Jong EMGJ, van de Kerkhof PCM. Recruitment of cycling epidermal cells and expression of fillagrin, involucrin and tenascin in the margin of the active psoriatic plaque, in the uninvolved skin of psoriatic patients and in the normal healthy skin. J Dermatol Sci 1997; 14: 179-188.
4. Lightner VA. Tenascin: does it play a role in epidermal morphogenesis and homeostasis? J Invest Dermatol 1994; 102: 273-277.
5. Lightner VA, Gumkowski F, Bigner DD, Erickson HP. Tenascin/hexabrachion in human skin: biochemical identification and localization by light and electron microscopy. J Cell Biol 1989; 108: 2483-2493.
6. Shikata N, Oyaizu T, Andachi H, Tsubura A. Tenascin expression in normal human adult skin and skin appendage tumours. Virchows Arch 1994; 424: 511-516.
7. Sakakura T, Kusakabe M. Can tenascin be redundant in cancer development? Perspect Dev Neurobiol 1994; 2: 111-116.
8. Verstraeten AA, Mackie EJ, Hageman PC, Hilgers J, Schol DJ, de Jongh GJ, et al. Tenascin expression in basal cell carcinoma. Br J Dermatol 1992; 127: 571-574.
9. Schalkwijk J, Steijlen PM, van Vlijmen Willems IM, Oosterling B, Mackie EJ, Verstraeten AA. Tenascin expression in human dermis is related to epidermal proliferation. Am J Pathol 1991; 139: 1143-1150.
10. Latijnhouwers MAHE, Bergers M, Ponec M, Dijkman H, Andriessen MPN, Schalkwijk J. Human epidermal keratinocytes are a source of tenasein-C during wound healing. J Invest Dermatol 1997; 108: 776-783.
11. Latijnhouwers MA, Bergers M, Vanbergen BH, Spruijt KI, Andriessen MP, Schalkwijk J. Tenascin expression during wound healing in human skin. J Pathol 1996; 178: 30-35.
12. Chiquet Ehrismann R, Hagios C, Schenk S. The complexity in regulating the expression of tenascins. Bioassays 1995; 17: 873-878.
13. Saga Y, Yagi T, Ikawa Y, Sakakura T, Aizawa S. Mice develop normally without tenascin. Genes Dev 1992; 6: 1821-1831.
14. Schenk S, Muser J, Vollmer G, Chiquet Ehrismann R. Tenascin-C in serum: a questionable tumor marker. Int J Cancer 1995; 61: 443-449.
15. Seyger MMB, van Pelt JPA, van den Born J, Latijnhouwers MA, de Jong EMGJ. Epicutaneous application of leukotriene B4 induces patterns of tenascin and a heparan sulfate proteoglycan epitope that are typical for psoriatic lesions. Arch Dermatol Res 1997; 289: 331-336.
16. Kuijpers ALA, Bergers M, Siegenthaler G, Zeeuwen PLJM, van de Kerkhof PCM, Schalkwijk J. Skin-derived antileukoproteinase (SKALP) and epidermal fatty acid-binding protein (F-FABP): two novel markers of the psoriatic phenotype that respond differentially to topical steroid. Acta Derm Venereol (Stockh) 1997; 77: 14-19.
17. Ekblom M, Fassler R, Tomasini Johansson B, Nilsson K, Ekblom P. Downregulation of tenasein expression by glucocorticoids in bone marrow stromal cells and in fibroblasts. J Cell Biol 1993; 123: 1037-1045.
18. Fässler R, Sasaki T, Timpl R, Chu ML, Werner S. Differential regulation of fibulin, tenascin-C, and nidogen expression during wound healing of normal and glucocorticoid-treated mice. Exp Cell Res 1996; 222: 111-116.
19. Talts JF, Weller A, Timpl R, Ekblom M, Ekblom P. Regulation of mesenchymal extracellular matrix protein synthesis by transforming growth factor-beta and glucocorticoids in tumor stroma. J Cell Sci 1995; 108: 2153-2162.
20. Schenk S, Muser J, Vollmer G, Chiquet Ehrismann R. Tenascin-C in serum: an acute-phase protein or a carcinoma marker? [letter]. Int J Cancer 1995; 60: 145.